Access consortium

ACCESS CONSORTIUM

September 19, 2022

What is the Access Consortium? The consortium is a medium-sized coalition of regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK that work together to promote greater regulatory collaboration and alignment of regulatory requirements.

Its purpose is to build synergies and maximize cooperation to ensure patients´ timely access to safe therapeutic products in member countries.

Find all related information about the Access Consortium here:

Flyer Acces Consortium Asphalion Regulatory Affairs

For further information, you can send us an email at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

PragmaTIL | Second Annual Meeting

Asphalion expert Núria García participated last week in the 2nd Annual PragmaTIL Consortium Meeting in Amsterdam, hosted by the Netherlands Cancer Institute (NKI). This two-day

EVENT | RAPS EuroConvergence 2025

At ASPHALION we are pleased to announce our participation in RAPS EuroConvergence 2025, one of the premier regulatory affairs events in Europe. This year’s conference

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting